56,966 blogs · [ { "id": "01a0e21b-9abe-7301-842f-ab06cb020e8d", "title": "This week in charts: Novo’s rise and fall and AI biotechs’ big haul", "url": "https://www.biopharmadive.com/news/novo-nordisk-share-price-ai-drug-discovery/831366/", "published_at": "2026-09-25T16:08:00+00:00" }, { "id": "01a0e21b-9abf-7102-b9cc-360baabeb8b4", "title": "Novo pursues long-acting obesity drugs; Acadia slumps on Alzheimer’s data", "url": "https://www.biopharmadive.com/news/novo-nanexa-acadia-remlifanserin-nektar-lilly-onswik-welireg/831346/", "published_at": "2026-09-25T13:21:00+00:00" }, { "id": "01a0e21b-9abf-7102-b9cc-360bab730714", "title": "RNAi drug specialist ADARx raises $446M IPO", "url": "https://www.biopharmadive.com/news/adarx-rnai-biotech-ipo-stock-pricing/831262/", "published_at": "2026-09-25T00:36:00+00:00" }, { "id": "01a0e21b-9abf-7102-b9cc-360babe4a9c6", "title": "Grail multicancer detection test wins FDA advisers’ backing", "url": "https://www.biopharmadive.com/news/grail-multicancer-detection-test-wins-fda-advisers-backing/831286/", "published_at": "2026-09-24T21:08:00+00:00" }, { "id": "01a0e21b-9abf-7102-b9cc-360bac6082d4", "title": "FDA nominee Overton parries vaccine questions at Senate hearing", "url": "https://www.biopharmadive.com/news/overton-senate-hearing-fda-vaccines-abortion-china/831285/", "published_at": "2026-09-24T20:46:00+00:00" }, { "id": "01a0e21b-9abf-7102-b9cc-360bac688ce1", "title": "Merck reveals study success, and possible safety worries, for eye drug hopeful", "url": "https://www.biopharmadive.com/news/merck-remigromig-dme-study-results-eyebio/831234/", "published_at": "2026-09-24T15:34:00+00:00" }, { "id": "01a0e21b-9abf-7102-b9cc-360bacd24ccb", "title": "Lilly’s latest China drug deal; Immunovant’s setback in lupus", "url": "https://www.biopharmadive.com/news/lilly-innocare-immunovant-vertex-inaxaplin-otsuka-ionis/831044/", "published_at": "2026-09-24T14:14:00+00:00" }, { "id": "01a0e21b-9abf-7102-b9cc-360bad54a877", "title": "Enveda, an AI drugmaker, banks $311M in venture funding", "url": "https://www.biopharmadive.com/news/enveda-ai-drug-discovery-series-e/831161/", "published_at": "2026-09-23T17:55:00+00:00" }, { "id": "01a0e21b-9abf-7102-b9cc-360bae43ceb0", "title": "Roche, Ionis RNA drug scores in kidney disease study", "url": "https://www.biopharmadive.com/news/roche-ionis-rna-study-iga-nephropathy/831152/", "published_at": "2026-09-23T16:21:56+00:00" }, { "id": "01a0e21b-9abf-7102-b9cc-360baee8c35a", "title": "9 pharma leaders sound ‘alarm bells’ on biotech’s decline in Europe", "url": "https://www.biopharmadive.com/news/europe-biotech-investment-decline-letter-pharma-chairs/831112/", "published_at": "2026-09-23T15:13:51+00:00" } ] posts Claim your blog

Back to biopharmadive.com

Blog · corpus.blog/blogs/biopharmadive.com/posts

biopharmadive.com

biopharmadive.com

2026

This week in charts: Novo’s rise and fall and AI biotechs’ big haul original ↗

25 Sept 2026

Novo pursues long-acting obesity drugs; Acadia slumps on Alzheimer’s data original ↗

25 Sept 2026

RNAi drug specialist ADARx raises $446M IPO original ↗

25 Sept 2026

Grail multicancer detection test wins FDA advisers’ backing original ↗

24 Sept 2026

FDA nominee Overton parries vaccine questions at Senate hearing original ↗

24 Sept 2026

Merck reveals study success, and possible safety worries, for eye drug hopeful original ↗

24 Sept 2026

Lilly’s latest China drug deal; Immunovant’s setback in lupus original ↗

24 Sept 2026

Enveda, an AI drugmaker, banks $311M in venture funding original ↗

23 Sept 2026

Roche, Ionis RNA drug scores in kidney disease study original ↗

23 Sept 2026

9 pharma leaders sound ‘alarm bells’ on biotech’s decline in Europe original ↗

23 Sept 2026